Results 251 to 260 of about 291,045 (316)

Single-Cell transcriptomic profiles of peripheral blood immune cells reveal early monocyte and platelet activation in the transition from high-risk states to clinical sepsis. [PDF]

Sci Rep
Sun L, Zhang P, Zhang H, Fan H, Li Y, Zhao Y, Wang M, Huang Y, Liu M, Zhang D, Zhang X.   +10 more
europepmc   +1 more source

Complex Pattern of Platelet Activation/Reactivity After SARS-CoV-2 Infection. [PDF]

Int J Mol Sci
Luzak B, Golanski J, Rozalski M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet antithrombin activity

Thrombosis Research, 1980
Abstract Platelets were studied for the presence of antithrombin (thrombin amidolytic inhibitory) activity. Platelet rich plasma contained more antithrombin activity than platelet poor plasma. This activity could be washed from a platelet pellet. Antithrombin activity increased on sonication of platelets but not following aggregation.
E E, Czapek, H C, Kwaan
openaire   +2 more sources

Platelet Activation and Atherothrombosis

New England Journal of Medicine, 2007
This review of the role of platelets in atherothrombosis illuminates the surprisingly numerous activities of these tiny, anucleate cells and stresses their participation in the inflammatory component of atherothrombosis. The information is presented in the context of the prevention of atherothrombosis by antiplatelet agents now in clinical use.
DAVI', Giovanni, PATRONO C.
openaire   +4 more sources

Platelet-Activating Factor

2007
Platelet-activating factor (PAF) is a potent mediator that occurs at very low concentrations in cells and tissues. Accurate quantitation of PAF has always been difficult because of the physicochemical properties of PAF and its structural similarity to several much more abundant phospholipids.
John S, Owen, Michael J, Thomas, Robert L, Wykle   +2 more
openaire   +2 more sources

Platelet Activity in Washed Platelet Concentrates

Anesthesia & Analgesia, 2004
Life-threatening anaphylaxis or febrile nonhemolytic transfusion reactions after transfusion of platelet concentrates (PCs) is a serious clinical problem caused by the sensitizing of recipients to plasma components, such as immunoglobulin A, or by cytokines. There is a possible indication for washing of PCs in these thrombocytopenic patients.
Helge, Schoenfeld, Manfred, Muhm, Ulrich, Doepfmer, Aristomenis, Exadaktylos, Hartmut, Radtke   +4 more
openaire   +2 more sources

Cisplatin Triggers Platelet Activation

Thrombosis Research, 2000
Clinical observations suggest that anticancer drugs could contribute to the thrombotic complications of malignancy in treated patients. Thrombotic microangiopathy, myocardial infarction, and cerebrovascular thrombotic events have been reported for cisplatin, a drug widely used in the treatment of many solid tumours.
TOGNA, Giuseppina Ines, TOGNA, Anna Rita, Matteo Franconi, CAPRINO, Luciano   +3 more
openaire   +2 more sources

Platelet-activating factor receptor

Prostaglandins & Other Lipid Mediators, 2002
Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a biologically active phospholipid mediator. Although PAF was named for its potential to induce platelet aggregation, intense investigations have elucidated potent biological actions of PAF in a broad range of cell types and tissues.
Zen-ichiro, Honda, Satoshi, Ishii, Takao, Shimizu   +2 more
openaire   +3 more sources